Organisation paid for research Program year 2025 Source: CMS Open Payments

WR-ClinSearch, LLC

Neither a doctor nor a teaching hospital

Research payments

$676,126

209 payments

Through program year 2025, WR-ClinSearch, LLC is reported as receiving $676,126 in research payments, across 209 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$13,053	4
2024	Research	$13,050	6
2023	Research	$43,687	6
2022	Research	$4,213	2
2021	Research	$215,887	155
2020	Research	$300,950	24
2019	Research	$85,286	12

Breakdown

Who paid Research payments · program years 2019–2025

Rhythm Pharmaceuticals, Inc. $108,157 7 payments
Ironwood Pharmaceuticals, Inc $106,951 10 payments
Abbott Laboratories $98,009 4 payments
Medicines360 $94,004 14 payments
H. Lundbeck A S $71,452 3 payments
HemoSonics LLC $61,130 2 payments
Vanda Pharmaceuticals Inc. $51,421 10 payments
Mitsubishi Tanabe Pharma Development America, Inc. $46,676 4 payments
Seqirus USA Inc $13,053 4 payments
Bausch Health US, LLC $13,050 6 payments

Studies the money was for Research payments · program years 2019–2025

Rm-493-014 $107,327 5 payments
Clinical Evaluation of the Investigational ID NOW COVID-19 Assay $98,009 4 payments
A Phase 3 multicenter, open-label study of a Levonorgestrel 52 mg Intrauterine System for the treatment of heavy Menstrual Bleeding $94,004 14 payments
C3718-301 $72,152 6 payments
Evaluate Efficacy & Safety of Eptinezumab Administered Intravenously in Subjects Experiencing Acute Attack of Migraine (RELIEF) $71,452 3 payments
Reference Range Study for the Quantra QStat System $61,130 2 payments
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of MT-2990 in Women with Endometriosis Experiencing Endometrial Related Pain $47,726 5 payments
McP-103-205 $34,763 3 payments
Evaluating the Effects of Tradipitant Vs. Placebo in Atopic Dermatitis $25,150 6 payments
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Assess the Efficacy of Tradipitant in Relieving Symptoms of Gastroparesis $15,443 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.